Works matching IS 26882663 AND DT 2025 AND VI 6 AND IP 6


Results: 36
    1
    2
    3
    4
    5
    6
    7
    8

    Issue Information.

    Published in:
    MedComm, 2025, v. 6, n. 6, p. 1, doi. 10.1002/mco2.70251
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Phase II Trial of Hypofractionated Radiotherapy and Immunochemotherapy in Primary Refractory Diffuse Large B‐Cell Lymphoma: Preliminary Results and Insights from Digital Spatial Profiling.

    Published in:
    MedComm, 2025, v. 6, n. 6, p. 1, doi. 10.1002/mco2.70225
    By:
    • Yang, Yong;
    • Yu, Jing;
    • Hu, Xiao‐Mei;
    • Chen, Si‐Lin;
    • Zhao, Rui‐Zhi;
    • Huang, Cheng;
    • Guo, Jiang‐Rui;
    • Tang, Tian‐Lan;
    • Chen, Cheng;
    • Lin, Yu‐Ping;
    • Wang, Ying;
    • Liu, Tian‐Xiu;
    • Zheng, Hao;
    • Liao, Si‐Qin;
    • Chen, Jin‐Hua;
    • Fu, Hai‐Ying;
    • Liu, Ting‐Bo
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Long Noncoding RNA Interleukin 6 Antisense RNA 1 Promotes Inflammatory Effects in Lung Macrophages via Exosomes Through the S100A9/TLR4 Pathway in Chronic Obstructive Pulmonary Disease Progression.

    Published in:
    MedComm, 2025, v. 6, n. 6, p. 1, doi. 10.1002/mco2.70204
    By:
    • Yi, Erkang;
    • Wang, Xiaoyu;
    • Liu, Yu;
    • Wang, Zihui;
    • Bai, Ge;
    • Mei, Xinyue;
    • Wu, Fan;
    • Xie, Chengshu;
    • Li, QiYang;
    • Cao, Weitao;
    • Xu, Huahua;
    • Liu, Xinyuan;
    • Cui, Jieda;
    • Li, Haiqing;
    • Sun, Ruiting;
    • Ran, Xinru;
    • Hong, Wei;
    • Deng, Zhishan;
    • Li, Bing;
    • Zhou, Yumin
    Publication type:
    Article
    32
    33
    34
    35
    36